Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Fraser Mitchell"'
Autor:
Fraser Mitchell
Publikováno v:
Forum: Qualitative Social Research, Vol 16, Iss 3 (2015)
Secondary analysis of data is seen as a way of maximising the utility of existing research in a non-intrusive way and provides an efficient research strategy at a time of financial constraint. However, there are few examples from the published litera
Externí odkaz:
https://doaj.org/article/c93182479a6642dea3bfe3bc7dd22c6e
Autor:
Daniel P Bray, Khatijah Yaman, Beryl A Underhilll, Fraser Mitchell, Victoria Carter, James G C Hamilton
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 12, p e3316 (2014)
BACKGROUND:The sand fly Phlebotomus argentipes is arguably the most important vector of leishmaniasis worldwide. As there is no vaccine against the parasites that cause leishmaniasis, disease prevention focuses on control of the insect vector. Unders
Externí odkaz:
https://doaj.org/article/dcfc1a5f060f4a8fbc61533d1a8bcbca
Publikováno v:
Oral Surgery. 16:118-121
Autor:
Eric O. Aboagye, Ann L. Jackman, Oksana Golovko, Franklin I. Aibgirhio, Julius Leyton, Fraser Mitchell, Meg Perumal, Martin Forster, Radhakrishna G. Pillai
Supplementary Figure 3 from Imaging Pharmacodynamics of the α-Folate Receptor–Targeted Thymidylate Synthase Inhibitor BGC 945
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb475700d3ba3764ac501d6234f7e43
https://doi.org/10.1158/0008-5472.22373709
https://doi.org/10.1158/0008-5472.22373709
Autor:
Ann L. Jackman, Elisa Henderson, Vassilios Bavetsias, Fraser Mitchell, Martin D. Forster, Melanie Valenti, Florence Raynaud, Matthew Green, Nadya Wood, Davinder S. Theti, David D. Gibbs
BGC 945 is a cyclopenta[g]quinazoline–based, thymidylate synthase inhibitor specifically transported into α-folate receptor (α-FR)–overexpressing tumors. Affinity of BGC 945 for the α-FR is 70% of the high-affinity ligand folic acid. In contra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c4e2ec2a7b73cd5371c1c39e0a449b7
https://doi.org/10.1158/0008-5472.c.6494742
https://doi.org/10.1158/0008-5472.c.6494742
Autor:
Ann L. Jackman, Elisa Henderson, Vassilios Bavetsias, Fraser Mitchell, Martin D. Forster, Melanie Valenti, Florence Raynaud, Matthew Green, Nadya Wood, Davinder S. Theti, David D. Gibbs
Supplementary Methods from BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to α-Folate Receptor–Overexpressing Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2e1a33768dbbe1cf0b3a90db850f70
https://doi.org/10.1158/0008-5472.22365534.v1
https://doi.org/10.1158/0008-5472.22365534.v1
Autor:
Eric O. Aboagye, Ann L. Jackman, Oksana Golovko, Franklin I. Aibgirhio, Julius Leyton, Fraser Mitchell, Meg Perumal, Martin Forster, Radhakrishna G. Pillai
Supplementary Figure 2 from Imaging Pharmacodynamics of the α-Folate Receptor–Targeted Thymidylate Synthase Inhibitor BGC 945
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93359985245364567ab0041bb2d11386
https://doi.org/10.1158/0008-5472.22373712.v1
https://doi.org/10.1158/0008-5472.22373712.v1
Autor:
Eric O. Aboagye, Ann L. Jackman, Oksana Golovko, Franklin I. Aibgirhio, Julius Leyton, Fraser Mitchell, Meg Perumal, Martin Forster, Radhakrishna G. Pillai
Supplementary Figure Legends 1-3 from Imaging Pharmacodynamics of the α-Folate Receptor–Targeted Thymidylate Synthase Inhibitor BGC 945
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1f47cbe157a8a44b7d1e4a8a46a89b
https://doi.org/10.1158/0008-5472.22373706
https://doi.org/10.1158/0008-5472.22373706
Autor:
Eric O. Aboagye, Ann L. Jackman, Oksana Golovko, Franklin I. Aibgirhio, Julius Leyton, Fraser Mitchell, Meg Perumal, Martin Forster, Radhakrishna G. Pillai
Supplementary Figure 1 from Imaging Pharmacodynamics of the α-Folate Receptor–Targeted Thymidylate Synthase Inhibitor BGC 945
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34930e59fdfe4be8bc3a9146a8d62b1c
https://doi.org/10.1158/0008-5472.22373718
https://doi.org/10.1158/0008-5472.22373718
Autor:
Eric O. Aboagye, Ann L. Jackman, Oksana Golovko, Franklin I. Aibgirhio, Julius Leyton, Fraser Mitchell, Meg Perumal, Martin Forster, Radhakrishna G. Pillai
The assessment of tissue-specific pharmacodynamics is desirable in the development of tumor-targeted therapies. Plasma deoxyuridine (dUrd) levels, a measure of systemic thymidylate synthase (TS) inhibition, has limited application for studying the ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ef0d89521a37fd92bc011a1edcf6aa
https://doi.org/10.1158/0008-5472.c.6497175
https://doi.org/10.1158/0008-5472.c.6497175